Daxor wins US patent for remote blood volume monitoring technology
DXR•Patent covers remote blood volume monitoring
Daxor received U.S. Patent No. 12,635,917 B2 on June 2, 2026 for a Remote Blood Volume Monitor.
The patent covers continuous, wearable-sensor monitoring tied to a baseline blood volume analysis measurement to flag clinically meaningful volume shifts.
Management framed the intellectual property as extending beyond point-of-care testing into chronic disease management, including heart failure, syncope and anemia.
